Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 3,293.90
-49.05 (-1.47%)
At close: Sep 4, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 34.18 billion as of September 4, 2026. Its market cap has increased by 233.93% in one year.
Market Cap
34.18B
Enterprise Value
35.43B
Revenue
5.54B
Ranking
n/a
PE Ratio
42.17
Stock Price
3,293.90
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 34.18B, an increase of 14,704.04%. That is a compound annual growth rate of 63.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 34.18B | 197.19% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 71.07B |
| Morepen Laboratories | 62.30B |
| FDC Limited | 55.79B |
| Gufic Biosciences | 44.67B |
| Novartis India | 40.42B |
| Unichem Laboratories | 38.79B |
| Hikal | 27.40B |
| Fredun Pharmaceuticals | 24.38B |